Global Axillary Hyperhidrosis Drug Market Insights and Forecast to 2031

Report ID: 1561710 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Axillary Hyperhidrosis Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Botulinum ToxinA
        1.2.3 Glycopyrrolate
        1.2.4 Glycopyrronium Tosylate
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Home Care
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Axillary Hyperhidrosis Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Axillary Hyperhidrosis Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Axillary Hyperhidrosis Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Axillary Hyperhidrosis Drug Sales by Region
        2.4.1 Global Axillary Hyperhidrosis Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Axillary Hyperhidrosis Drug by Region (2023-2028)
    2.5 Global Axillary Hyperhidrosis Drug Revenue by Region
        2.5.1 Global Axillary Hyperhidrosis Drug Revenue by Region (2017-2022)
        2.5.2 Global Axillary Hyperhidrosis Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Axillary Hyperhidrosis Drug Sales by Manufacturers
        3.1.1 Global Top Axillary Hyperhidrosis Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Axillary Hyperhidrosis Drug in 2021
    3.2 Global Axillary Hyperhidrosis Drug Revenue by Manufacturers
        3.2.1 Global Axillary Hyperhidrosis Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Axillary Hyperhidrosis Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Axillary Hyperhidrosis Drug Revenue in 2021
    3.3 Global Axillary Hyperhidrosis Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Axillary Hyperhidrosis Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Axillary Hyperhidrosis Drug Sales by Type
        4.1.1 Global Axillary Hyperhidrosis Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Axillary Hyperhidrosis Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    4.2 Global Axillary Hyperhidrosis Drug Revenue by Type
        4.2.1 Global Axillary Hyperhidrosis Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Axillary Hyperhidrosis Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Axillary Hyperhidrosis Drug Price by Type
        4.3.1 Global Axillary Hyperhidrosis Drug Price by Type (2017-2022)
        4.3.2 Global Axillary Hyperhidrosis Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Axillary Hyperhidrosis Drug Sales by Application
        5.1.1 Global Axillary Hyperhidrosis Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Axillary Hyperhidrosis Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    5.2 Global Axillary Hyperhidrosis Drug Revenue by Application
        5.2.1 Global Axillary Hyperhidrosis Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Axillary Hyperhidrosis Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Axillary Hyperhidrosis Drug Price by Application
        5.3.1 Global Axillary Hyperhidrosis Drug Price by Application (2017-2022)
        5.3.2 Global Axillary Hyperhidrosis Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Axillary Hyperhidrosis Drug Market Size by Type
        6.1.1 North America Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
        6.1.2 North America Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
    6.2 North America Axillary Hyperhidrosis Drug Market Size by Application
        6.2.1 North America Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
        6.2.2 North America Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
    6.3 North America Axillary Hyperhidrosis Drug Market Size by Country
        6.3.1 North America Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
        6.3.2 North America Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Axillary Hyperhidrosis Drug Market Size by Type
        7.1.1 Europe Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
        7.1.2 Europe Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
    7.2 Europe Axillary Hyperhidrosis Drug Market Size by Application
        7.2.1 Europe Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
        7.2.2 Europe Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
    7.3 Europe Axillary Hyperhidrosis Drug Market Size by Country
        7.3.1 Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
        7.3.2 Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Type
        8.1.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Application
        8.2.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Region
        8.3.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Axillary Hyperhidrosis Drug Market Size by Type
        9.1.1 Latin America Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
        9.1.2 Latin America Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
    9.2 Latin America Axillary Hyperhidrosis Drug Market Size by Application
        9.2.1 Latin America Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
        9.2.2 Latin America Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
    9.3 Latin America Axillary Hyperhidrosis Drug Market Size by Country
        9.3.1 Latin America Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
        9.3.2 Latin America Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
        9.3.6 Colombia
10 Middle East and Africa
    10.1 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Type
        10.1.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Application
        10.2.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country
        10.3.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Allergan Plc
        11.1.1 Allergan Plc Corporation Information
        11.1.2 Allergan Plc Overview
        11.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Allergan Plc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Allergan Plc Recent Developments
    11.2 Brickell Biotech Inc
        11.2.1 Brickell Biotech Inc Corporation Information
        11.2.2 Brickell Biotech Inc Overview
        11.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Brickell Biotech Inc Recent Developments
    11.3 Dermira Inc
        11.3.1 Dermira Inc Corporation Information
        11.3.2 Dermira Inc Overview
        11.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Dermira Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Dermira Inc Recent Developments
    11.4 Dr. August Wolff GmbH & Co KG Arzneimittle
        11.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Corporation Information
        11.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Overview
        11.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments
    11.5 GlaxoSmithKline Plc
        11.5.1 GlaxoSmithKline Plc Corporation Information
        11.5.2 GlaxoSmithKline Plc Overview
        11.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline Plc Recent Developments
    11.6 TheraVida Inc
        11.6.1 TheraVida Inc Corporation Information
        11.6.2 TheraVida Inc Overview
        11.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 TheraVida Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Axillary Hyperhidrosis Drug Industry Chain Analysis
    12.2 Axillary Hyperhidrosis Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Axillary Hyperhidrosis Drug Production Mode & Process
    12.4 Axillary Hyperhidrosis Drug Sales and Marketing
        12.4.1 Axillary Hyperhidrosis Drug Sales Channels
        12.4.2 Axillary Hyperhidrosis Drug Distributors
    12.5 Axillary Hyperhidrosis Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Axillary Hyperhidrosis Drug Industry Trends
    13.2 Axillary Hyperhidrosis Drug Market Drivers
    13.3 Axillary Hyperhidrosis Drug Market Challenges
    13.4 Axillary Hyperhidrosis Drug Market Restraints
14 Key Findings in The Global Axillary Hyperhidrosis Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Botulinum ToxinA
    Table 3. Major Manufacturers of Glycopyrrolate
    Table 4. Major Manufacturers of Glycopyrronium Tosylate
    Table 5. Major Manufacturers of Others
    Table 6. Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Axillary Hyperhidrosis Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Axillary Hyperhidrosis Drug Sales by Region (2017-2022) & (K Pcs)
    Table 9. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Axillary Hyperhidrosis Drug Sales by Region (2023-2028) & (K Pcs)
    Table 11. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Axillary Hyperhidrosis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Axillary Hyperhidrosis Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Axillary Hyperhidrosis Drug Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 17. Global Axillary Hyperhidrosis Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Axillary Hyperhidrosis Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Axillary Hyperhidrosis Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Axillary Hyperhidrosis Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 21. Global Axillary Hyperhidrosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Axillary Hyperhidrosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Axillary Hyperhidrosis Drug as of 2021)
    Table 23. Axillary Hyperhidrosis Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Axillary Hyperhidrosis Drug Product Offered
    Table 25. Date of Manufacturers Enter into Axillary Hyperhidrosis Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 28. Global Axillary Hyperhidrosis Drug Sales by Type (2023-2028) & (K Pcs)
    Table 29. Global Axillary Hyperhidrosis Drug Sales Share by Type (2017-2022)
    Table 30. Global Axillary Hyperhidrosis Drug Sales Share by Type (2023-2028)
    Table 31. Global Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Axillary Hyperhidrosis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Axillary Hyperhidrosis Drug Revenue Share by Type (2017-2022)
    Table 34. Global Axillary Hyperhidrosis Drug Revenue Share by Type (2023-2028)
    Table 35. Axillary Hyperhidrosis Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 36. Global Axillary Hyperhidrosis Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 37. Global Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
    Table 38. Global Axillary Hyperhidrosis Drug Sales by Application (2023-2028) & (K Pcs)
    Table 39. Global Axillary Hyperhidrosis Drug Sales Share by Application (2017-2022)
    Table 40. Global Axillary Hyperhidrosis Drug Sales Share by Application (2023-2028)
    Table 41. Global Axillary Hyperhidrosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Axillary Hyperhidrosis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Axillary Hyperhidrosis Drug Revenue Share by Application (2017-2022)
    Table 44. Global Axillary Hyperhidrosis Drug Revenue Share by Application (2023-2028)
    Table 45. Axillary Hyperhidrosis Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 46. Global Axillary Hyperhidrosis Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 47. North America Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 48. North America Axillary Hyperhidrosis Drug Sales by Type (2023-2028) & (K Pcs)
    Table 49. North America Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Axillary Hyperhidrosis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
    Table 52. North America Axillary Hyperhidrosis Drug Sales by Application (2023-2028) & (K Pcs)
    Table 53. North America Axillary Hyperhidrosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Axillary Hyperhidrosis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 56. North America Axillary Hyperhidrosis Drug Sales by Country (2023-2028) & (K Pcs)
    Table 57. North America Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Axillary Hyperhidrosis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 60. Europe Axillary Hyperhidrosis Drug Sales by Type (2023-2028) & (K Pcs)
    Table 61. Europe Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Axillary Hyperhidrosis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
    Table 64. Europe Axillary Hyperhidrosis Drug Sales by Application (2023-2028) & (K Pcs)
    Table 65. Europe Axillary Hyperhidrosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Axillary Hyperhidrosis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 68. Europe Axillary Hyperhidrosis Drug Sales by Country (2023-2028) & (K Pcs)
    Table 69. Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Axillary Hyperhidrosis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 72. Asia Pacific Axillary Hyperhidrosis Drug Sales by Type (2023-2028) & (K Pcs)
    Table 73. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
    Table 76. Asia Pacific Axillary Hyperhidrosis Drug Sales by Application (2023-2028) & (K Pcs)
    Table 77. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2017-2022) & (K Pcs)
    Table 80. Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2023-2028) & (K Pcs)
    Table 81. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 84. Latin America Axillary Hyperhidrosis Drug Sales by Type (2023-2028) & (K Pcs)
    Table 85. Latin America Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Axillary Hyperhidrosis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
    Table 88. Latin America Axillary Hyperhidrosis Drug Sales by Application (2023-2028) & (K Pcs)
    Table 89. Latin America Axillary Hyperhidrosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Axillary Hyperhidrosis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 92. Latin America Axillary Hyperhidrosis Drug Sales by Country (2023-2028) & (K Pcs)
    Table 93. Latin America Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Axillary Hyperhidrosis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2017-2022) & (K Pcs)
    Table 96. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2023-2028) & (K Pcs)
    Table 97. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2017-2022) & (K Pcs)
    Table 100. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2023-2028) & (K Pcs)
    Table 101. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2022) & (K Pcs)
    Table 104. Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2023-2028) & (K Pcs)
    Table 105. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Allergan Plc Corporation Information
    Table 108. Allergan Plc Description and Major Businesses
    Table 109. Allergan Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. Allergan Plc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Allergan Plc Recent Developments
    Table 112. Brickell Biotech Inc Corporation Information
    Table 113. Brickell Biotech Inc Description and Major Businesses
    Table 114. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Brickell Biotech Inc Recent Developments
    Table 117. Dermira Inc Corporation Information
    Table 118. Dermira Inc Description and Major Businesses
    Table 119. Dermira Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Dermira Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Dermira Inc Recent Developments
    Table 122. Dr. August Wolff GmbH & Co KG Arzneimittle Corporation Information
    Table 123. Dr. August Wolff GmbH & Co KG Arzneimittle Description and Major Businesses
    Table 124. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments
    Table 127. GlaxoSmithKline Plc Corporation Information
    Table 128. GlaxoSmithKline Plc Description and Major Businesses
    Table 129. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 130. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. GlaxoSmithKline Plc Recent Developments
    Table 132. TheraVida Inc Corporation Information
    Table 133. TheraVida Inc Description and Major Businesses
    Table 134. TheraVida Inc Axillary Hyperhidrosis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 135. TheraVida Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. TheraVida Inc Recent Developments
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Axillary Hyperhidrosis Drug Distributors List
    Table 140. Axillary Hyperhidrosis Drug Customers List
    Table 141. Axillary Hyperhidrosis Drug Market Trends
    Table 142. Axillary Hyperhidrosis Drug Market Drivers
    Table 143. Axillary Hyperhidrosis Drug Market Challenges
    Table 144. Axillary Hyperhidrosis Drug Market Restraints
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Axillary Hyperhidrosis Drug Product Picture
    Figure 3. Global Axillary Hyperhidrosis Drug Market Share by Type in 2021 & 2028
    Figure 3. Botulinum ToxinA Product Picture
    Figure 4. Glycopyrrolate Product Picture
    Figure 5. Glycopyrronium Tosylate Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Axillary Hyperhidrosis Drug Market Share by Application in 2021 & 2028
    Figure 8. Clinic
    Figure 9. Hospital
    Figure 10. Home Care
    Figure 11. Axillary Hyperhidrosis Drug Report Years Considered
    Figure 12. Global Axillary Hyperhidrosis Drug Sales 2017-2028 (K Pcs)
    Figure 13. Global Axillary Hyperhidrosis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Axillary Hyperhidrosis Drug Revenue 2017-2028 (US$ Million)
    Figure 15. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2017-2022)
    Figure 17. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2023-2028)
    Figure 18. North America Axillary Hyperhidrosis Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 19. North America Axillary Hyperhidrosis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Axillary Hyperhidrosis Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 21. Europe Axillary Hyperhidrosis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Axillary Hyperhidrosis Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Asia-Pacific Axillary Hyperhidrosis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Axillary Hyperhidrosis Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Latin America Axillary Hyperhidrosis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Axillary Hyperhidrosis Drug Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Middle East & Africa Axillary Hyperhidrosis Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Axillary Hyperhidrosis Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Axillary Hyperhidrosis Drug in the World: Market Share by Axillary Hyperhidrosis Drug Revenue in 2021
    Figure 30. Global Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    Figure 32. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    Figure 33. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    Figure 34. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    Figure 35. North America Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    Figure 36. North America Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    Figure 37. North America Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    Figure 38. North America Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    Figure 39. North America Axillary Hyperhidrosis Drug Sales Share by Country (2017-2028)
    Figure 40. North America Axillary Hyperhidrosis Drug Revenue Share by Country (2017-2028)
    Figure 41. U.S. Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    Figure 44. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    Figure 46. Europe Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Axillary Hyperhidrosis Drug Sales Share by Country (2017-2028)
    Figure 48. Europe Axillary Hyperhidrosis Drug Revenue Share by Country (2017-2028)
    Figure 49. Germany Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. France Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Axillary Hyperhidrosis Drug Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Axillary Hyperhidrosis Drug Revenue Share by Region (2017-2028)
    Figure 60. China Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. India Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Axillary Hyperhidrosis Drug Sales Share by Country (2017-2028)
    Figure 75. Latin America Axillary Hyperhidrosis Drug Revenue Share by Country (2017-2028)
    Figure 76. Mexico Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Colombia Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Axillary Hyperhidrosis Drug Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Axillary Hyperhidrosis Drug Revenue Share by Country (2017-2028)
    Figure 86. Turkey Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. UAE Axillary Hyperhidrosis Drug Revenue (2017-2028) & (US$ Million)
    Figure 89. Axillary Hyperhidrosis Drug Value Chain
    Figure 90. Axillary Hyperhidrosis Drug Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan Plc
Brickell Biotech Inc
Dermira Inc
Dr. August Wolff GmbH & Co KG Arzneimittle
GlaxoSmithKline Plc
TheraVida Inc
Frequently Asked Questions
Axillary Hyperhidrosis Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Axillary Hyperhidrosis Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Axillary Hyperhidrosis Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports